BioLoomics
PrivateLast Round
Seed
Sep 19, 2023
Total Funding Raised
$10.12M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioLoomics is a biotechnology company that develops antibody-drug conjugates (ADCs) for cancer therapies using directed evolution, synthetic biology, and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioLoomics Comparables
Compare BioLoomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiverse | 83% | |
| AvantGen, Inc. | 79% | |
| BigHat Biosciences | 77% | |
BioLoomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 19, 2023 | ||||
| Pre Seed | May 11, 2021 | ||||
| Grant | Nov 21, 2019 | ||||
| Pre Seed | May 30, 2019 |
BioLoomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Seed |
| Horizons Ventures | Seed |
| TechU Ventures | Seed |
| Innovation Endeavors | Seed |
| Boom Capital | Seed |
| BoxOne Ventures | Seed |
| Hummingbird Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 684% MoM to 1.3K.
- Sep 19, 2023
$9M round led by Innovation Endeavors
BioLoomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioLoomics's valuation, stock price, and market status.